Skip to main content

Peer Review reports

From: Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience

Original Submission
17 Feb 2022 Submitted Original manuscript
4 Mar 2022 Reviewed Reviewer Report
21 Mar 2022 Reviewed Reviewer Report
21 Apr 2022 Author responded Author comments - Antonio Russo
Resubmission - Version 2
21 Apr 2022 Submitted Manuscript version 2
22 Apr 2022 Editorially accepted
13 Jun 2022 Article published 10.1186/s10194-022-01436-6

You can find further information about peer review here.

Back to article page